Jacobs Levy Equity Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Other funds holding VYGR
OM
Jacobs Levy Equity Management's VYGR Position: Q3 2026 in Review
Jacobs Levy Equity Management opened a new position in Voyager Therapeutics (VYGR) in Q3 2026: 328,754 shares worth $881K. The stake represents ﹤0.01% of the portfolio and ranks #689 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in VYGR as recently as Q2 2025.
Jacobs Levy Equity Management first reported a position in VYGR in Q2 2018 and has held it in 15 quarters since. The position peaked at $2.64M in Q1 2021. 121 funds tracked by Wall St. Rank hold VYGR as of Q3 2026.
- Jacobs Levy Equity Management held 328,754 shares of Voyager Therapeutics worth $881K as of Q3 2026.
- Voyager Therapeutics was a new Jacobs Levy Equity Management position in Q3 2026.
- Voyager Therapeutics made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q3 2026, its #689 holding.
- Jacobs Levy Equity Management first reported a position in Voyager Therapeutics in Q2 2018 and has held it in 15 quarters since.
- Jacobs Levy Equity Management's Voyager Therapeutics position peaked at $2.64M in Q1 2021.
- 121 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2026, filed 16 Nov 2026.